SMAD3 and neoplasm: The specific role of Smad3 on NK cell-mediated antitumour activities was further examined by adoptive transfer of Smad3+/+ or Smad3−/− NK1.1+ cells into the B16F10 tumour-bearing NOD/SCID mice in which the NK cell population was deficient28.